News

  • Transition of CEO role

    Posted on 15 May 2013

    The Board of Photonz Corporation is delighted to announce the appointment of Dr James Campbell to the role of CEO as part of a staged transition that sees Dr Greg Collier assume the CEO role of the ASX-listed biotech company Invion Limited. 

  • Photonz's Chief Scientific Officer Wins NZBIO Award

    Posted on 20 March 2013

    Dr Hywel Griffiths, Chief Scientific Officer for Photonz Corp. was named the 2013 Young Biotechnologist of the Year by NZBIO at an award ceremony Tuesday evening.

     

  • Seeking commercial partners

    Posted on 9 November 2012

    AUCKLAND via ALGAE WORLD ASIA CONFERENCE SINGAPORE – 8 November 2012 – Talks are underway involving potential partners of Photonz Corporation as the company is finalising its process for manufacturing eicosapentaenoic acid (EPA) by fermentation of micro-algae.

 

Archive of News

Viewing 1 to 10 of 20
2 

Archived Stories

Transition of CEO role

Posted on 15 May 2013

The Board of Photonz Corporation is delighted to announce the appointment of Dr James Campbell to the role of CEO as part of a staged transition that sees Dr Greg Collier assume the CEO role of the ASX-listed biotech company Invion Limited. 

Photonz's Chief Scientific Officer Wins NZBIO Award

Posted on 20 March 2013

Dr Hywel Griffiths, Chief Scientific Officer for Photonz Corp. was named the 2013 Young Biotechnologist of the Year by NZBIO at an award ceremony Tuesday evening.

 

Seeking commercial partners

Posted on 9 November 2012

AUCKLAND via ALGAE WORLD ASIA CONFERENCE SINGAPORE – 8 November 2012 – Talks are underway involving potential partners of Photonz Corporation as the company is finalising its process for manufacturing eicosapentaenoic acid (EPA) by fermentation of micro-algae.

Photonz in the spotlilght

Posted on 6 November 2012

New Zealand based Photonz Corporation would soon enter a new phase of being a commercial-ready producer of eicosapentaenoic acid (EPA) from fermented algae, a major biotech summit in Australia has been told.

Radio interview

Posted on 4 September 2012

Hywel Griffiths, Chief Scientific Officer of Photonz Corporation Ltd was featured on radio station bFM.

Photonz successfully transfers process to industrial scale

Posted on Nov. 21 2011

Photonz Corporation has achieved a major milestone on the path to commercially manufacturing, by fermentation, the high-value omega-3 fatty acid, EPA...

Photonz signs with Novasep

Posted on Sep. 21 2011

Biotech company Photonz Corporation has entered into a development agreement with Novasep, a world-class provider of purification technology...

Photonz Corporation signs with Separex

Posted on Apr. 6, 2011

Under the agreement Separex, under a license of Stanipharm, will develop a manufacturing process, scalable to industrial volumes, to concentrate the Omega-3 fatty acid, eicosapentaenoic acid (EPA), which Photonz extracts from fermented microalgal biomass...

Photonz receives $2.9 million R+D Grant

Posted on Mar. 28, 2011

Awarded under the TechNZ programme, the grant will enable the biotech company to undertake work that will, when completed, allow it to commence commercial production of the omega-3 fatty acid eicosapentaenoic acid (EPA) from marine micro-algae....

Dr. Douglas Wilson appointed to Board of Directors

Posted on Aug. 13, 2010

Dr John Douglas Wilson has been appointed to the Board of Directors, adding considerable skill and experience from the pharmaceutical sector ahead of the Series B capital raising round....

Archive of News

Viewing 1 to 10 of 20
2